|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's Range||62.16 - 63.71|
|52 Week Range||31.80 - 63.71|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 26, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||65.95|
BCE's fourth-quarter results reflect healthy top-line growth at Bell Wireless and Bell Media that led to higher overall service revenues.
T-Mobile (TMUS) delivers all-time high financial results, including service and total revenues, as well as record adjusted EBITDA, in fourth-quarter 2019.
Nokia's (NOK) fourth-quarter results reflect strong growth with enterprise customers, driven by increased demand for mission-critical networking solutions.
Anaplan, Inc. (NYSE: PLAN), a pioneer in Connected Planning, today announced the winners of the company’s annual Partner Awards, which recognize global and regional partners for their role in helping customers transform their businesses through Connected Planning. This year’s winners exemplify a customer-first mentality, delivering the sector expertise customers need to drive growth and deliver value through digital transformation.
Viavi's (VIAV) fiscal second-quarter results reflect strong performance of Network and Service Enablement, and Optical Security and Performance Products business segments.
Business-planning software maker Anaplan uses a strong partner ecosystem to compete against bigger rivals Oracle, SAP and Workday. Anaplan's strategy has fueled revenue growth above 40%.
The Dow Jones rose Tuesday as stocks swiftly recover from last week’s coronavirus sell-off. Earnings after the close include Disney stock and Chipotle.
If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained more than 57% each. Hedge funds' top 3 stock picks returned 44.6% this year and beat the S&P 500 […]
The cloud-based planning software provider Anaplan Inc's (NYSE: PLAN ) near-term as well as long-term growth prospects are encouraging, according to Rosenblatt Securities. The Analyst Yun Kim has a Buy ...
It has definitely been a stellar year for enterprise cloud stocks. Just look at companies like Anaplan (NYSE:PLAN), Okta (NASDAQ:OKTA) and Docusign (NASDAQ:DOCU). They have all posted over 80% returns.Source: Shutterstock But the news has not been as good for old-line enterprise companies, especially those that rely heavily on on-premises solutions. One example is VMware (NYSE:VMW) stock. Consider that the return is a measly 10.6%. * 7 Safe Dividend Stocks for Investors to Buy Right Now Founded in 1998, VMware is the pioneer of virtualization for the x86 architecture, allowing for much better performance from existing machines. But with the secular trend towards the cloud, the business has come under pressure. For the most part, there has been a move away from traditional virtualization to the use of containers that hold apps, configurations and settings.InvestorPlace - Stock Market News, Stock Advice & Trading TipsInterestingly enough, the origins of this technology go to Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG), which needed to find ways to scale their cloud applications. The company's engineers developed a framework, called Kubernetes, that allows for this. About five years ago, Google open sourced this, making the technology a standard.Now while containers and Kubernetes are clear threats to VMW stock, it's important to keep in mind that the company is not sitting back. That is, there has been a big push for M&A, including about $5 billion in recent deals for Pivotal Software (NYSE:PVTL) and Carbon Black.So why these companies? Well, let's take a look: Carbon BlackCarbon Black, which is a cybersecurity company, came public in May 2018 at $19 a share. VMW agreed to buy the company for $26 per share.For the most part, this deal is about expanding the footprint. No doubt, cybersecurity is a top-of-mind priority for companies. The risks keep increasing as new technologies like cloud and mobile penetrate the enterprise. Regarding Carbon Black, its technology is targeted on endpoints, whether physical or virtual where sensitive data is located. The company has also been leveraging next-generation approaches like AI (Artificial Intelligence).With the deal, VMware will launch a new Security Business Unit. And it should represent a nice avenue for growth and cross-selling.Carbon Black has over 5,600 customers and reported a 19% increase in revenues during the latest quarter to $60.9 million. Although, the cloud revenues jumped by 68% to $22.9 million. Pivotal SoftwarePivotal Software is another recent IPO that came out in April 2018. The initial offering price was $15, which is what VMware ultimately agreed to pay for the company.Pivotal Software operates a software platform that helps with the building, deployment and operation of cloud-native and legacy applications. But the company has also been leveraging its technology with Kubernetes. Pivotal Software has launched an alpha version of its Pivotal Application Service (PAS) for this. Then there was a partnership with VMware last year for the Pivotal Container Service, which allows for scaling Kubernetes.True, the growth rate for Pivotal is not too impressive, at 17% during the latest quarter. But like Carbon Black, the cloud business is growing quickly, at 38%. Consider that Pivotal believes its market opportunity is $50 billion. Bottom Line VMW StockWhile VMware's M&A strategy is risky, it's the best way to transition to the cloud. What's more, the dealmaking will likely continue. As seen with other mature tech companies like Adobe (NASDAQ:ADBE) and Microsoft (NASDAQ:MSFT), the transformation process can result in strong gains for shareholders.Oh, and for VMW stock, the valuation is currently at fairly cheap levels, with the price-to-earnings ratio at only about 9x. So for investors looking for an interesting value play, this one fits the bill.Tom Taulli is the author of the book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Vaping Stocks to Get into Ahead of the Crowd * 5 Retail Stocks That Are Winning Big This Holiday Season * Make the Shift Toward Value Stocks With These 5 Picks The post VMware's M&A Strategy Looks Spot On appeared first on InvestorPlace.
We dive into five technology stocks that investors might want to buy for 2020, as stocks continue to climb on U.S.-China trade positivity heading into the new year...
We found three cloud-focused software stocks using our Zacks Stock Screener that investors might want to consider buying for 2020...
The Cambridge Dictionary’s definition of an expert is a “person with a high level of knowledge or skill relating to a particular subject or activity.”Apply this to the investing world, and how do we see this in action? We pull out TipRanks’ Top Wall Street Firms and notice who sits at the top of the heap.Occupying the throne right now is renowned investment bank RBC Capital, which means that among the company’s employees there are seasoned pros with a proven track record for success. Utilizing the TipRanks Stock Screener tool, we’ve found three stocks receiving Strong Buy ratings from most analysts in general, and endorsed by RBC in particular. Let’s take a closer look: Ovid Therapeutics (OVID)Ovid Therapeutics shares are on a tear. The stock price of this neurological medicines firm has raced ahead 66% this year, leaving the Nasdaq Biotechnology ETF (IBB) in its dust. But would you believe it has even further to run? Would you believe it could go up another 200%? RBC analyst Brian Abrahams does. In his latest research note, Abrahams reiterated an Outperform rating on OVID, along with a price target of $12.00 (To watch Abraham’s track record, click here)The drug maker has several therapies in the pipeline. Leading programs in development right now are OV101, which focuses on a potential treatment for Angelman syndrome and Fragile X syndrome, two neurodevelopmental disorders caused by genetic mutations, and OV935, a program focused on developing potential therapies for people living with rare epilepsies.Top-line data from a Phase 3 NEPTUNE trial of OV101 in Angelman's Syndrome should be released in mid-2020, and Abrahams thinks there is a very reasonable chance of success. While acknowledging some risk given disease heterogeneity, unclear dose dependence, and inconsistent subdomain effects in ph.II, the 5-star analyst noted, “We believe clinical and preclinical data for the company's lead candidate OV101, an extrasynaptic GABAA receptor agonist, are in totality supportive of the drug's activity in Angelman Syndrome, and believe the stock price currently underappreciates the likelihood the drug succeeds in improving clinical symptoms of the disease in ph.III. Given the high unmet need in this population, we believe FDA will be permissive -- highlighted by the Agency's endorsement of the pivotal trial design -- and if approved, should enable good uptake and pricing power.”Other analysts are even more optimistic. Indeed, the average price target on Wall Street is $13.50 -- implying nearly 240% upside. And over the last three months, no one on the Street has assigned Ovid shares anything less than a "buy" rating. (See Ovid stock analysis on TipRanks)Anaplan (PLAN)This year has seen a number of car crash IPO’s, as several over valued startups got on the receiving end of a harsh reality check following public listings. One to avoid such a fate, is cloud computing ‘connected planning’ platform, Anaplan.The company’s name derives from the combination of analysis and planning, which makes sense to us, as it makes software that connects people in a shared environment to business data in order to make better-informed plans and decisions.Anaplan impressed Wall Street with its latest F3Q20 earnings report. The company handily beat expectations on several key metrics, including top-line, billings, and margins. Additionally, this led to management significantly boosting its FY20 guidance.RBC’s Alex Zukin believes that a ‘large addressable market’ can serve as a catalyst for Anaplan’s growth, noting, “Anaplan indicates that the Planning market is a $21B+ opportunity (based on IDC forecasts). We believe customers are paying legacy vendors billions of dollars today and there is potential for spend significantly above that if greenfield, excel-based business processes meaningfully start to convert to Planning vendors.”Anaplan’s growth potential has Zukin reiterating his Outperform rating, along with a price target of $70. PLAN is currently trading at $52.56, indicating gains of 33% might be in the cards should Zukin’s target materialize. (To watch Zukin’s track record, click here)What’s the Street’s plan for PLAN, then? The consensus is that the connected planning innovator is a Strong Buy, a rating achieved as a result of 9 "buy" and 3 "hold" ratings issued in the past 3 months. The average stock-price forecast of $63.33 implies upside potential of 20% from current levels. (See PLAN stock analysis on TipRanks)Analog Devices (ADI)Last and least, we come to semiconductor maker Analog Devices, which scored an "outperform" rating (i.e. "buy") from 5-star RBC analyst Mitch Steves.ADI stock is up nearly 38% in 2019 compared to the S&P 500, which has returned 24%. That’s impressive, but the big question for investors is whether the company (and its stock) can maintain the momentum. Steves suggests that if everything goes as planned, ADI will be a $136 stock in the next 12 months, implying about 18% return. (To watch Steves’ track record, click here)The company’s recent FQ4 numbers were mildly below Street expectations. Revenues of $1.44 billion slightly missed the Street’s estimate of $1.45 billion, while EPS of $1.19 came below the $1.22 estimate. FQ1 guidance also missed the Street’s targets.Steves commented, “We continue to believe that sentiment is still quite negative on the stock and remain positive as operating margin expansion should begin in Q2 and beyond [...] We remain positive on ADI and its suggestion of a recovery in Q2 is in line with our Analog view as well.” The analyst further added, “We are seeing positive trends within ADI’s communications business, as the company manages to sustain share gain and capture 5G opportunities. Being exposed to 5G radio content represents significant differentiation relative to the analog group, in our view.”The RBC expert is not alone in his take on ADI, as 11 Buys and 3 Holds from the analysts tracked by TipRanks over the last 3 months result in a Strong Buy consensus rating. The average price target stands at $125.57. (See ADI stock analysis on TipRanks)
Anaplan, Ryder System, Applied Materials, Ubiquiti and Aspen Technology highlighted as Zacks Bull and Bear of the Day
Software was one of the areas that we've been talking about showing relative strength and you had a whole host of names leading today. Anaplan showed a breakout above resistance around 60.Unprofitable but solid revenue growth.